Do not store vials at 25C to 15C (-13F to 5F). Thermal Shipping Container with Dry Ice Pellets. or During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light. If the vaccine is frozen, it must be discarded. Prepare the vaccine using a NEW vial of diluent and a NEW vial of vaccine EVERY TIME. You can get more information from your health care professional via the FDA Fact Sheet for Recipients and Caregivers, the Health Canada Patient Medication Information, or the Informed Consent Form for a study. /Type /StructTreeRoot 12 Years of Age and Older (Purple Cap) Pfizer-BioNTech COVID-19 Vaccine Statewide Standing Orders for Administering Vaccine Do Not Administer the Pfizer-BioNTech COVID-19 vaccine if contraindications or precautions are identified through screening, refer to primary care provider for further evaluation Contraindications: History of a: History of anaphylactic reaction to any component of the vaccineis generally considered a contraindication, however for more details on the administration of COVID-19 vaccines to individuals with allergies to components of the COVID-19 vaccines, please see the 88 0 R 89 0 R 89 0 R 90 0 R 91 0 R 92 0 R] /ModDate (D:20211021154608+00'00') 1 0 obj endobj If you got the product for free, and your systems require a product code to bill for the administration, enter $0.01 for the billed amount. /IDTree 10 0 R /Filter /FlateDecode p`pI0@$\ \b @1 W W+ +PL(& /Parent 2 0 R /BleedBox [0.0 7.9200063 612.0 799.92] ] On October 12, 2022, the FDA authorized the Moderna bivalent product (dark blue cap with gray border) and its administration for use as a single booster dose in individuals 12 years through 17 years of age in addition to the 8/31/2022 FDA authorization as a single booster dose in individuals 18 years and older. Providers should only bill Medicare for commercially-purchased products. >> /X24 24 0 R >> Regardless of storage condition, vaccines should not be used after 12 months from the date of manufacture printed on the vial and cartons. /Count 2 Pfizer-BioNTech COVID-19 Vaccine. Once vials are thawed they should not be refrozen. Refer to the re-icing guidelines packed in the original thermal container for instructions regarding the use of the thermal container for temporary storage. CDC has updated its recommendations for COVID-19 vaccines with a preference for people to receive an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna) Subject: . COVID-19 bivalent BA.4/BA.5 variant vaccines should be administered as a booster no sooner than two months after a prior dose of COVID-19 vaccine has been used to complete the primary series or as a booster. /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] Purple Cap: Monovalent Pfizer-BioNTech COVID-19 Vaccines Espaol Storage and Handling Resources Follow CDC's and manufacturer's guidance for vaccine storage. 12 0 obj /TrimBox [0.0 7.9200063 612.0 799.92] COVID-19 Vaccine Resource Guide for Pfizer COVID-19 Vaccine Pfizer (mRNA): Maroon Cap Pfizer (mRNA)2: Orange Cap Pfizer (mRNA)3: Purple Cap Pfizer (mRNA)4: Gray Cap DO NOT DILUTE Primary Series for Immunocompetent Individuals Age Indication 6 months through 4 yrs. /G3 11 0 R /Title (PfizerPurpleCap Oct 21) Once received, frozen vials may be immediately transferred to the refrigerator [2C to 8C (35F to 46F)], thawed and stored for a single period of up to 10 weeks within the 12-month shelf-life. Payment Allowances and Effective Dates for COVID-19 Monoclonal Antibodies and their Administration During the Public Health Emergency: Pfizer-BioNTech COVID-19 Vaccine Letter of Authorization, [For claims with dates of service 3/15/2021 through 12/31/2021], Updated 10/25/2022 to reflect the new code for Novavax COVID-19 vaccine, Adjuvanted, [For claims with dates of service 10/19/2022 through 12/31/2022, Part B Biosimilar Biological Product Payment and Required Modifiers. (accessibility) on other federal or private websites. Pfizer covid drug cost. A: The minimum quantity of Pfizer Tris Sucrose vaccine that can be shipped from the manufacturer is 300 doses. Once received, remove the vial cartons immediately from the thermal container and preferably store in an ultra-low temperature freezer between 90C to -60C (-130F to -76F) until the expiry date printed on the label. There are new storage, handling, and administration requirements for Pfizer Tris Sucrose-gray cap: The Pfizer-BioNTech COVID-19 vaccine is administered in two doses, 3 weeks apart. The shipper will include five boxes, each containing 60 doses. If not previously thawed at 2C to 8C (35F to 46F), allow vials to thaw at room temperature [up to 25C (77F)] for 30 minutes. Q: Will the gray cap vaccine be sent in boxes similar to the orange cap instead of the large square boxes the purple cap vaccine came in? [5]On June 3, 2021, the FDA revised the EUA for casirivimab and imdevimab to change the allowed dosing regimen from 2400 mgto 1200 mg, and allow providers to administer the combination product by subcutaneous injection in limited circumstances. << The Pfizer-BioNTech COVID-19 Vaccine is supplied as a frozen suspension in multiple dose vials with purple caps; each vial must be diluted with 1.8 mL of sterile 0.9% Sodium Chloride Injection . >> Thawed vials can be handled in room light conditions. largest craft shows in the us 2021 endobj >> [9] On January 24, 2022, the FDA announced that, due to the high frequency of the Omicron variant, this product isnt currently authorized in any U.S region and may not be administered for treatment or post-exposure prevention of COVID-19 under the EUA until further notice by the FDA. Pfizer-BioNTech COVID-19 Vaccine, Bivalent may be stored at room temperature [8C to 25C (46F to 77F)] for a total of 12 hours prior to the first puncture. For more information, review the COVID-19 provider toolkit. Any hours used for transport at 2C to 8C (35F to 46F) count against the 1-month limit for storage at 2C to 8C (35F to 46F). To date, safety data on the vaccine has been collected from 37,586 participants enrolled in an ongoing. [6] On October 12, 2022, the FDA authorized the Moderna bivalent product (dark blue cap with gray border) and its administration for use as a single booster dose in individuals 12 years through 17 years of age in addition to the 8/31/2022 FDA authorization as a single booster dose in individuals 18 years and older. As a result, CMS issued a new product code for casirivimab and imdevimab (Q0244) and updated the descriptors for the existing administration codes (M0243/M0244). endobj Table 1. >> Vaccine Reactions, Screening endobj /Type /ParentTree Cartons of COMIRNATY multiple dose vials (for 12 years and older: DO NOT DILUTE) may also arrive at 2C to 8C. Cartons of COMIRNATY (for age 5 years to <12 years) and COMIRNATY (for age 6 months to <5 years) may also arrive at 2C to 8C (35F to 46F). The Pfizer coronavirus vaccine may be linked to a form of eye inflammation called uveitis, according to a multicenter Israeli study led by . A carton of 25 vials or 195 vials may take up to 2 or 3 hours, respectively, to thaw in the refrigerator, whereas a fewer number of vials will thaw in less time. /Resources << You can decide how often to receive updates. as Pfizer-BioNTech COVID-19 Vaccine. /Resources << May be returned one time to the recommended storage condition of-90 . /TrimBox [0.0 7.9200063 612.0 799.92] /DisplayDocTitle true p`pI0@$\ \b @1 W W+ +PL(& The Pfizer-BioNTech COVID-19 Vaccine authorized for use in children 5 through 11 years of age should not be used interchangeably with COMIRNATY (COVID-19 Vaccine, mRNA). 91300 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use. (The Associated Press/CBC) 12 years and older 12 years and older >> /X10 15 0 R In Walgreens's case, you have to generate a QR code in order to download your COVID -19 vaccine card. Pfizer-BioNTech Comirnaty COVID-19 vaccine The vaccine If received at 2C to 8C, they should be stored at 2C to 8C. Recipient age: 5 - 11 years. Pfizer (purple cap) fizer (gray cap) Pfizer (orange cap) Moderna (full dose and booster dose) Janssen Storage (Prior to Puncture) The COVID-19 Vaccine Storage, Preparation and Administration Chart is a guide for vaccine providers that reects best practices for vaccine storage and handling Cartons of COMIRNATY multiple dose vials (for age 5 years to <12 years) and COMIRNATY multiple dose vials (for age 6 months to <5 years) may arrive frozen at ultra-cold conditions in thermal containers with dry ice. Handouts, Mandatory >> ) 53 0 R 54 0 R 54 0 R 55 0 R 56 0 R] 3 0 obj Linking to a non-federal Website does not constitute an 7 0 obj There are three presentations of the COVID-19 Vaccine Pfizer/BioNTech authorised for use in Great Britain, two of which are currently available: The original 30 microgram/dose presentation. Vials should be discarded 12 hours after first puncture. Providers and suppliers should use Q0245 and M0245 or M0246 to bill for administering bamlanivimab and etesevimab for PEP. /BleedBox [0.0 7.9200063 612.0 799.92] News, BILLING . Oct 19, 2022 1978 porsche 930 turbo for sale bible verses about god39s forgiveness and love. Jan-May 2021 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), May-Dec 2021 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), Jan - March 2021 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), March - Dec 2021 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), Jan - Dec 2022 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), Jan - Dec 2022 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), Pfizer-BioNTech COVID-19 Vaccine, Bivalent Product (Aged 12 years and older) (Gray Cap), Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Gray Cap) Administration Booster Dose, Moderna COVID-19 Vaccine, Bivalent Product (Aged 12years and older) (Dark Blue Cap with gray border), Moderna COVID-19 Vaccine, Bivalent (Aged 12years and older) (Dark Blue Cap with gray border) Administration Booster Dose. Thawed Under Refrigeration: Thaw and then store undiluted vials in the refrigerator (2C to 8C [35F to 46F]) for up to 1 month. Pfizer-BioNTech Comirnaty COVID-19 vaccine The vaccine is approved for people who are 6 months of age and older. (See. An illustrative photo of the Pfizer COVID-19 vaccine. /StructParents 1 As seen with older age groups, it is expected that vaccines for younger children will provide protection from the most severe COVID-19 . /ExtGState << Providers should track these time frames. Pfizer vaccine 1170 (with the purple cap) is being retired and a new formulation of Pfizer vaccine for adults/adolescents will be available soon. Pfizer COVID Vaccination At a Glance Contraindications and Precautions Preparation and Administration Summary Standing Orders Purple Cap-12 years of age and older Gray Cap-12 years of age and older (Updated: 9/12/22) Orange Cap- 5 through 11 years of age Maroon Cap-6 months through 4 years of age (Updated: 6/20/22) Infographics These resources are designed to increase the number of providers that can administer the products and ensure adequate reimbursement for administration in Medicare, while making it clear to private insurers and Medicaid programs their responsibility to cover these products at no charge to beneficiaries. Vials After DilutionAfter dilution, store vials between 2C to 25C (35F to 77F) and use within 6 hours from the time of dilution. The mRNA in these vaccines is a specific piece of genetic material that instructs cells in the body to make the distinctive "spike" protein of the original virus strain and the omicron variant lineages BA.4 and. /ID (node00375960) A carton of 10 vials may take up to 6 hours to thaw at this temperature. Children ages 5-11 years old: 10 0 obj Guidance for spacing of a bivalent booster vaccine following SARS-CoV-2 infection is the same as with prior booster recommendations. Refer to the, CDC has updated its recommendations for COVID-19 vaccines with a preference for people to receive an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna), urn:sha256:3d33333cbdf385503d41c72b015d9a4b0919405f10a6b211fd2070b0e45ee5e8, Centers for Disease Control and Prevention (U.S.), Intended for print onlyCS321571-D 1storage-handling-label.pdf. /F15 18 0 R Pfizer-BioNTech COVID-19 Vaccine is supplied in a multiple-dose vial with a purple cap and a label with a purple border. /ColorSpace /DeviceRGB /Type /Catalog After first puncture, the multiple dose vial should be held between 2C to 25C (35F to 77F). >> 73 0 R 74 0 R 75 0 R 76 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 80 0 R /F15 18 0 R >> Both the Johnson &. 2022 Pfizer. [6]On July 30, 2021, the FDA revised the EUA for casirivimab and imdevimab to allow its use for post-exposure prophylaxis (PEP) in certain adult and pediatric patients. /K [26 0 R] >> Long, medium, and short descriptors of COVID-19 CPT codes are available from AMA website. policy when you follow the link. Alternatively, frozen vials may be stored in an ultra-low temperature freezer at 90C to 60C ( 130F to 76F) for up to 12 months from the date of manufacture. 45 0 R 46 0 R 47 0 R 48 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 52 0 R 0004A 9/22/2021 Pfizer-BioNTech Covid-19 Vaccine (Purple Cap) Administration - Booster 42.14 91301 12/18/2020 Moderna Covid-19 Vaccine (Aged 12 years and older) (Red Cap) N/A (currently government supplied at no cost to the provider) Updated September 14, 2022 Would you like to proceed? Vials of the Pfizer-BioNTech COVID-19 vaccine intended for individuals 12 years of age and . /Kids [93 0 R] 81 0 R 81 0 R 82 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 87 0 R Pfizer COVID-19 Vaccine Pediatric Formulation1 (100 doses/pack) Adolescent/Adult Formulation1 (300 dose/pack) Adolescent/Adult . Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with a purple cap is authorized for use to provide: a 2-dose primary series to individuals 12 years of age and older; a. Pfizer-BioNTech COVID-19 vaccine (purple cap) age 12 and over December 23, 2021. As a result, CMS issued a new product code for casirivimab and imdevimab of 600 mg (Q0240), and 2 new codes for the administration of repeat doses of casirivimab and imdevimab (M0240/M0241). [4]Administration booster codes should be billed for all applicable booster doses as approved and/or authorized by the FDA. Dry ice replenishment every 5 days. For If local redistribution is needed, full cartons containing unpunctured vials may be transported at -90C to -60C (-130F to -76F); full cartons or individual unpunctured vials may also be transported at 2C to 8C (35F to 46F). Checklists, Standing Orders Medicare Monoclonal Antibody COVID-19 Infusion Program Instruction, COVID-19 CPT vaccine and immunization codes - AMA, Quick reference guide to the coding structure for COVID-19 vaccine CPT reporting, Casirivimab and imdevimab Emergency Use Authorization) (ZIP), Bamlanivimab and etesevimab Emergency Use Authorization, Evusheld (tixagevimab co-packaged with cilgavimab) Emergency Use Authorization, Bebtelovimab Emergency Use Authorization (PDF), Pfizer-BioNTech COVID-19 Vaccine Letter of Authorization (PDF), Moderna COVID-19 Vaccine Letter of Authorization (PDF), Janssen COVID-19 Vaccine Letter of Authorization, Novavax COVID-19 Vaccine, Adjuvanted Letter of Authorization, Fact Sheet for Healthcare Providers - Emergency Use Authorization of bamlanivimab, Fact Sheet for Healthcare Providers - Emergency Use Authorization of casirivimab and imdevimab, Fact Sheet for Healthcare Providers - Emergency Use Authorization of bamlanivimab and etesevimab, Fact Sheet for Healthcare Providers - Emergency Use Authorization of sotrovimab, Fact Sheet for Healthcare Providers Emergency Use Authorization of tocilizumab (ZIP), Fact Sheet for Healthcare Providers Emergency Use Authorization of Evusheld (tixagevimab co-packaged with cilgavimab) (ZIP), Fact Sheet for Healthcare Providers - Emergency Use Authorization of bebtelovimab, Fact Sheets for Healthcare Providers - Pfizer-BioNTech COVID-19 Vaccine, Fact Sheet for Healthcare Providers - Moderna COVID-19 Vaccine, Fact Sheet for Healthcare Providers - Janssen COVID-19 Vaccine, Fact Sheet for Healthcare Providers Emergency Use Authorization of Novavax COVID-19 Vaccine, Adjuvanted, Information about Public Health Emergency, COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals, 2020 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), 2020 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP), Jan-May 2021 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)[For claims with dates of service of 1/1/2021 through 5/5/2021], May-Dec 2021 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)*Updated 12/23/2021 to account fornew codes for tixagevimab co-packaged with cilgavimab* [For claims with dates of service 5/6/2021 through 12/31/2021], Jan - March 2021 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)*Updated February 16, 2021 for addition of the COVID-19 Janssen vaccine*[For claims with dates of service of 1/1/2021 through 3/14/2021], March - Dec 2021 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)*Updated 11/02/2021 to account for effective dates for Pfizer-BioNTech COVID-19 Pediatric Vaccine[For claims with dates of service 3/15/2021 through 12/31/2021], Jan - Dec 2022 Geographically-adjusted Payment Rates for Monoclonal Antibody Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)*Updated 02/17/2022 to reflect the new codes for bebtelovimab [For claims with dates of service 02/11/2022 through 12/31/2022], Jan - Dec 2022 Geographically-adjusted Payment Rates for COVID-19 Vaccine Administration (for Providers & Suppliers Paid MPFS-Adjusted Rates) (ZIP)*Updated 10/25/2022 to reflect the new code for Novavax COVID-19 vaccine, Adjuvanted booster dose [For claims with dates of service 10/19/2022 through 12/31/2022]. some features on this page may not work correctly. The extension is also applicable to batches that might have expired prior to this amendment. COVID-19 Vaccine Consent Form for Employees 28 COVID-19 Vaccines Federal Bureau of Prisons January 4, 2021, version 7.0 3 COVID-19 V ACCINE A. P URPOSE The purpose of this guidance is t o provide direction on use of the COVID-19. Pfizer says its coronavirus vaccine developed in partnership with BioNTech was more than 90% effective in preventing Covid-19 infection. /Type /XObject Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for use to prevent COVID-19 in individuals 5 years of age and older as a single booster dose administered at least 2 months after. /MediaBox [0.0 7.9200063 612.0 799.92] as of 1/24/22 . This is a multidose vial with a purple cap and must be diluted before use. [2]Given the limited clinical situations allowed under the EUA, providers should only bill for tocilizumab on a 12x type of bill (TOB). The dosage is one-third of the adolescent and adult dose. Pfizer provided 0.9% Sodium chloride Injection USP diluent for use with the PfizerBioNTech COVID-19 vaccine under the name of its subsidiary, Hospira. >> .gov endobj >> /Producer (Canva) /F17 20 0 R Vial labels and cartons may state that a vial should be discarded 6hours after dilution. /Parent 2 0 R << During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light. /BM /Normal [5] On June 17, 2022, FDA authorized the 50MCG/0.5ML presentation of the Moderna COVID-19 Vaccine to provide primary series doses in individuals 6 years through 11 years of age in addition to the 3/29/2022 FDA authorization to provide booster vaccination doses in individuals 18 years and older. [3]Johnson & Johnson COVID-19 vaccine. A significant number of doses, particularly the Pfizer Purple Cap original (monovalent) vaccine, expired on September 30, 2022. /Kids [6 0 R 7 0 R] View the Emergency Use Authorization. Alternatively, frozen vials may be stored in an ultra-low temperature freezer at 90C to 60C ( 130F to 76F). After dilution, the vaccine vials can be handled in room light conditions. 14 CLINICAL PHARMACOLOGY Vials stored at -25C to 15C (-13F to 5F) for up to 2 weeks may be returned one time to the recommended storage condition of -90C to -60C (-130F to -76F). National Payment Allowance Effective for Claims with DOS on or after 03/15/2021, National Payment Allowance Effective for Claims with DOS through 03/14/2021, Pfizer-BioNTech Covid-19 Vaccine (Aged 12 years and older) (Purple Cap), Pfizer-BioNTech Covid-19 Vaccine(Purple Cap) Administration First Dose, Pfizer-BioNTech Covid-19 Vaccine(Purple Cap) Administration Second Dose, Pfizer-BioNTech Covid-19 Vaccine(Purple Cap) Administration Third Dose, Pfizer-BioNTech Covid-19 Vaccine(Purple Cap) Administration Booster, Moderna Covid-19 Vaccine (Aged 12 years and older) (Red Cap), Moderna Covid-19 Vaccine(Red Cap) Administration First Dose, Moderna Covid-19 Vaccine(Red Cap) Administration Second Dose, Moderna Covid-19 Vaccine(Red Cap) Administration Third Dose, AstraZeneca Covid-19 Vaccine Administration First Dose, AstraZeneca Covid-19 Vaccine Administration Second Dose, Janssen Covid-19 Vaccine(Aged 18 years and older)[3], Janssen Covid-19 Vaccine Administration - First Dose[3], Janssen Covid-19 Vaccine Administration - Booster[3], Novavax Covid-19 Vaccine, Adjuvanted (Aged 12 years and older), Novavax Covid-19 Vaccine,Adjuvanted Administration First Dose, Novavax Covid-19 Vaccine,Adjuvanted Administration Second Dose, Novavax Covid-19 Vaccine, Adjuvanted Administration - Booster, Pfizer-BioNTech Covid-19 Vaccine Pre-Diluted (Aged 12 years and older)(Gray Cap), Pfizer-BioNTech Covid-19 Vaccine Pre-Diluted (Gray Cap) Administration - First dose, Pfizer-BioNTech Covid-19 Vaccine Pre-Diluted (Gray Cap) Administration - Second dose, Pfizer-BioNTech Covid-19 Vaccine Pre-Diluted (Gray Cap) Administration - Third dose, Pfizer-BioNTech Covid-19 Vaccine Pre-Diluted (Gray Cap) Administration - Booster, Moderna Covid-19 Vaccine(Aged 18 years and older) (Red Cap) (Low Dose), Moderna Covid-19 Vaccine (Red Cap) (Low Dose) Administration - Booster, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Aged 5 years through 11 years) (Orange Cap), Pfizer-BioNTech Covid-19 Pediatric Vaccine (Orange Cap) Administration - First dose, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Orange Cap) Administration - Second dose, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Orange Cap) Administration - Third dose, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Orange Cap)Administration - Booster, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Aged 6 months through 4 years) (Maroon Cap), Pfizer-BioNTech Covid-19 Pediatric Vaccine (Aged 6 months through 4 years) (Maroon Cap) Administration - First dose, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Aged 6 months through 4 years) (Maroon Cap)Administration - Second dose, Pfizer-BioNTech Covid-19 Pediatric Vaccine (Aged 6 months through 4 years) (Maroon Cap) Administration - Third dose, Moderna Covid-19 Vaccine (Aged 6 years through 11 years or aged 18 years and older) (Blue Cap with purple border) 50MCG/0.5ML[5], Moderna Covid-19 Pediatric Vaccine (Aged 6 years through 11 years) (Blue Cap with purple border) Administration - First dose, Moderna Covid-19 Pediatric Vaccine (Aged 6 years through 11 years) (Blue Cap with purple border) Administration - Second dose, Moderna Covid-19 Pediatric Vaccine (Aged 6 years through 11 years) (Blue Cap with purple border)Administration - Third dose, Moderna Covid-19 Vaccine (Aged 18 years and older) (Blue Cap with purple border) 50MCG/0.5ML Administration - Booster, Moderna Covid-19 Pediatric Vaccine (Aged 6 months through 5 years) (Blue Cap with magenta border) 250MCG/0.25ML, Moderna Covid-19 Pediatric Vaccine (Aged 6 months through 5 years) (Blue Cap with magenta border) Administration - First dose, Moderna Covid-19 Pediatric Vaccine (Aged 6 months through 5 years) (Blue Cap with magenta border) Administration - Second dose, Moderna Covid-19 Pediatric Vaccine (Aged 6 months through 5 years) (Blue Cap with magenta border) Administration - Third dose, Moderna COVID-19 Vaccine, Bivalent Product (Aged 6 years through 11 years) (Dark Blue Cap with gray border), Moderna COVID-19 Vaccine, Bivalent (Aged 6 years through 11 years) (Dark Blue Cap with gray border) Administration Booster Dose, Pfizer-BioNTech COVID-19 Vaccine, Bivalent Product (Aged 5 years through 11 years) (Orange Cap), Pfizer-BioNTech COVID-19 Vaccine, Bivalent Product (Aged 5 years through 11 years) (Orange Cap) Administration Booster Dose, Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home. Templates, Temperature expiration date tracking tool (PDF) to record updated expiration dates for COVID-19 vaccine.Document the current date, the vaccine lot number, and the updated expiration date.Do not discard vaccine without ensuring the expiration date has passed.Pfizer vaccine has the expiration date on the vial; for Moderna and Janssen, scan QR codes. Check that the carton has been updated to reflect the 10-week refrigerated expiry date. pvHWZ[x7-Ls;kk~ pCSw+0 rto aN 0:r5N+ The Moderna COVID-19 Vaccine , Bivalent and the Pfizer -BioNTech COVID-19 Vaccine , Bivalent contain mRNA from the SARS-CoV-2 virus. << Providers should not bill for the product if they received it for free. https:// The Moderna COVID19 vaccines are supplied in the following multiple-dose vial presentations: 5.5 mL vial with a red cap and blue border for primary series doses (12 years of age and older) 2.5 mL vial with a dark blue cap and purple border for primary series doses (6-11 years of age) Below is a table reviewing the storage and handling requirements for all of the Pfizer COVID-19 vaccine products. Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg, Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg, Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring, Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the covid-19 public health emergency, Intravenous injection, bebtelovimab, includes injection and post administration monitoring, Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the covid-19 public health emergency, Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring, Q0240[6]Note: This product isnt currently authorized[9], Injection, casirivimab and imdevimab, 600 mg, M0240[6]Note: This product isnt currently authorized[9], Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses, M0241[6]Note: This product isnt currently authorized[9], Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence, this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency,subsequent repeat doses, Q0243Note: This product isnt currently authorized[9], Injection, casirivimab and imdevimab, 2400 mg, M0243Note: This product isnt currently authorized[9], Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, Q0244[5]Note: This product isnt currently authorized[9], Injection, casirivimab and imdevimab, 1200 mg, M0244Note: This product isnt currently authorized[9], Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the covid-19 public health emergency, Q0245[8]Note: This product isnt currently authorized[9], Injection, bamlanivimab and etesevimab, 2100 mg, M0245[8]Note: This product isnt currently authorized[9], intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring, M0246[8]Note: This product isnt currently authorized[9], Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the covid-19 public health emergency, Note: This product isnt currently authorized[10], Intravenous infusion, sotrovimab, includes infusion and post administration monitoring, Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the covid-19 public health emergency, Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, 1 mg, Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose, Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose.

Pacific Foods Ultra Soy, Laboratory Experiments For General Chemistry, 4th Edition Pdf, Maintain Aspect Ratio Css, Microsoft 3d Viewer For Mac, Incidence Rate Definition Epidemiology, Heb Live Crawfish 2022, Effects Of The Syrian Drought, Detergent Manufacturers In Singapore, Specialized Rockhopper Expert Weight, K5 Learning Simplifying Fractions Answer Key, Ipswich Town Fa Cup Record,